Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ensysce Biosciences is a clinical-stage pharmaceutical company developing innovative opioid and pain management solutions. Its proprietary TAAP and MPAR platforms create abuse-resistant and overdose-protective prodrugs, aiming to reduce misuse, overdose, and addiction. The company focuses on safer opioid products for pain relief and opioid use disorder, targeting markets with high societal impact, leveraging novel molecular delivery technologies to improve safety and efficacy.
This description was generated via AI from an annual report. Updated about 1 year ago.